Axogen AXGN
NASDAQ AXGN
$47.27 +0.58 (+1.24%)
As of: Sep 9, 2026 · 3:59 PM EDT

Axogen (AXGN) Capital Expenditures (QoQ) (2012 - 2026)

Analysis

Axogen (AXGN) Capital Expenditures (QoQ) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 Axogen 2.51 Bn 2.40 Bn 50.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -67.98%
Mar 31, 2026 123.66%
Dec 31, 2025 -17.96%
Sep 30, 2025 110.53%
Jun 30, 2025 182.03%
Mar 31, 2025 -61.79%
Dec 31, 2024 12.23%
Sep 30, 2024 -34.40%
Jun 30, 2024 -1.52%
Mar 31, 2024 -36.84%
Dec 31, 2023 -60.35%
Sep 30, 2023 -16.42%
Jun 30, 2023 2.58%
Mar 31, 2023 -35.00%
Dec 31, 2022 51.53%
Sep 30, 2022 7.93%
Jun 30, 2022 -19.61%
Mar 31, 2022 -29.75%
Dec 31, 2021 -26.21%
Sep 30, 2021 59.61%